Hemostemix. Hemostemix is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy...
Hemostemix. Hemostemix is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy...
Never miss Hemostemix.com updates: Start reading the news feed of Hemostemix right away! Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Hemostemix.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
Valentin Fulga of Hemostemix joined us at Stem Cells & Regenerative Medicine Congress 2014 to present ‘ Hemostemix : Your cells, our technology’ Download the presentation now to learn about Advantages of ACP-01 Ischemic heart disease clinical...
TORONTO, ON--(Healthcare Sales & Marketing Network) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM) (OTCQX: HMTXF), a clinical-stage autologous cell therapy company, announced today the promotion of Hardean E. Achne... Regenerative...
Orbis Research Orbis Research Present’s Global Stem Cell Therapy Market 2017-2021 enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. About stem cell therapy Stem cell therapy...
Research teams based at the Universities of Dundee and Edinburgh are looking to partner with the pharmaceutical industry to better understand the biological processes that could allow the development of new drugs to support tissue regeneration or repair...
Regenerative Medicine Market Regenerative medicines hold the ability treplace, repair, and regenerate tissues and organs that are affected due tsome disease, injury, or natural ageing process. These medicines are capable of restoring the functionality...
John H. Barker | Germany | Institute for Face & Limb...
Apply the tools and know-how of medical science, clinical practice and industry to discover and develop better treatments for pati...
Neotherix | Regenerative Soft Tissue Healing...
Neotherix technology uses the body’s ability to repair itself. Our advances in soft tissue repair deliver cells with healing 3D ar...
Stem Cell Therapy for CLI - Hemostemix
Hemostemix is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases.
ACP-01 is a Phase 2 clinical candidate that uses a patient’s own cells to restore blood flow to ischemic limbs. Our technology is based on a significant body of clinical data indicating the regenerat...
Public Filings Public Filings A complete list of public filings is available on the SEDAR (System for Electronic Document Analysis and Retrieval) website.
13 years
Domain age
N/A
Visit duration
N/A
Daily visitors
N/A
Bounce rate
84.9 %
Canada